Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 13 | 2021 | 561 | 2.200 |
Why?
|
| Protein Kinase C | 14 | 2021 | 120 | 2.120 |
Why?
|
| Memory Disorders | 3 | 2023 | 73 | 1.650 |
Why?
|
| Memory | 10 | 2018 | 170 | 1.100 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 905 | 0.920 |
Why?
|
| Prostaglandin D2 | 3 | 2022 | 27 | 0.910 |
Why?
|
| Dendritic Spines | 4 | 2018 | 33 | 0.840 |
Why?
|
| Long-Term Potentiation | 10 | 2016 | 102 | 0.800 |
Why?
|
| Amygdala | 6 | 2021 | 114 | 0.790 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2021 | 65 | 0.760 |
Why?
|
| Receptors, AMPA | 8 | 2019 | 56 | 0.700 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2019 | 17 | 0.700 |
Why?
|
| Central Nervous System Stimulants | 1 | 2021 | 174 | 0.690 |
Why?
|
| Methamphetamine | 1 | 2021 | 159 | 0.690 |
Why?
|
| Maze Learning | 4 | 2021 | 105 | 0.640 |
Why?
|
| Animals | 37 | 2024 | 15081 | 0.610 |
Why?
|
| Rats | 20 | 2024 | 3483 | 0.600 |
Why?
|
| Male | 26 | 2023 | 20025 | 0.430 |
Why?
|
| Stress, Physiological | 1 | 2013 | 150 | 0.420 |
Why?
|
| Brain | 9 | 2019 | 1346 | 0.410 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2018 | 1618 | 0.400 |
Why?
|
| Rats, Transgenic | 4 | 2024 | 27 | 0.390 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 1371 | 0.380 |
Why?
|
| Mental Recall | 3 | 2016 | 78 | 0.380 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 131 | 0.340 |
Why?
|
| Memory, Short-Term | 3 | 2021 | 49 | 0.330 |
Why?
|
| Mice | 7 | 2023 | 5913 | 0.330 |
Why?
|
| Dopamine | 2 | 2021 | 245 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1609 | 0.320 |
Why?
|
| Fear | 3 | 2019 | 249 | 0.320 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 61 | 0.300 |
Why?
|
| Conditioning, Classical | 3 | 2019 | 61 | 0.280 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 162 | 0.270 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 197 | 0.270 |
Why?
|
| Avoidance Learning | 6 | 2017 | 62 | 0.270 |
Why?
|
| Estradiol | 2 | 2018 | 262 | 0.270 |
Why?
|
| Animals, Newborn | 3 | 2018 | 343 | 0.270 |
Why?
|
| Isoenzymes | 2 | 2008 | 161 | 0.260 |
Why?
|
| Opioid-Related Disorders | 1 | 2008 | 125 | 0.260 |
Why?
|
| Female | 14 | 2024 | 20969 | 0.250 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2017 | 34 | 0.250 |
Why?
|
| Sex Factors | 2 | 2021 | 898 | 0.250 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 617 | 0.250 |
Why?
|
| Chalcones | 1 | 2024 | 14 | 0.240 |
Why?
|
| Pyramidal Cells | 4 | 2011 | 63 | 0.240 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 173 | 0.230 |
Why?
|
| Ubiquitins | 1 | 2023 | 46 | 0.220 |
Why?
|
| Chickens | 5 | 1995 | 133 | 0.220 |
Why?
|
| Excitatory Postsynaptic Potentials | 6 | 2016 | 79 | 0.220 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 62 | 0.210 |
Why?
|
| Behavior, Animal | 2 | 2021 | 314 | 0.210 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2023 | 114 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 122 | 0.200 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2021 | 22 | 0.200 |
Why?
|
| Administration, Oral | 1 | 2021 | 224 | 0.190 |
Why?
|
| Microglia | 2 | 2019 | 166 | 0.190 |
Why?
|
| Anorexia Nervosa | 1 | 2020 | 6 | 0.190 |
Why?
|
| Corticosterone | 3 | 2017 | 77 | 0.180 |
Why?
|
| Neurons | 4 | 2019 | 1175 | 0.170 |
Why?
|
| Stress, Psychological | 2 | 2017 | 583 | 0.170 |
Why?
|
| Maternal Behavior | 1 | 2019 | 22 | 0.170 |
Why?
|
| Leupeptins | 1 | 2018 | 11 | 0.160 |
Why?
|
| Gene Expression | 4 | 2018 | 674 | 0.160 |
Why?
|
| Substantia Nigra | 1 | 2018 | 44 | 0.160 |
Why?
|
| Encephalitis | 1 | 2018 | 42 | 0.160 |
Why?
|
| Inflammation | 1 | 2023 | 618 | 0.160 |
Why?
|
| Glycoproteins | 1 | 2018 | 106 | 0.150 |
Why?
|
| Dominance-Subordination | 1 | 2017 | 6 | 0.150 |
Why?
|
| Pseudopodia | 1 | 2017 | 15 | 0.150 |
Why?
|
| Phenanthridines | 2 | 2002 | 3 | 0.140 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2013 | 21 | 0.140 |
Why?
|
| Neuronal Plasticity | 4 | 2019 | 103 | 0.130 |
Why?
|
| Estrogens | 1 | 2017 | 202 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2017 | 174 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 245 | 0.130 |
Why?
|
| Benzophenanthridines | 3 | 2008 | 9 | 0.130 |
Why?
|
| Rats, Long-Evans | 4 | 2019 | 89 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 187 | 0.130 |
Why?
|
| Appetitive Behavior | 1 | 1995 | 11 | 0.130 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2014 | 1 | 0.120 |
Why?
|
| Learning | 3 | 2018 | 117 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1994 | 40 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 27 | 0.120 |
Why?
|
| Aging | 3 | 2016 | 664 | 0.120 |
Why?
|
| Nerve Net | 1 | 2014 | 76 | 0.110 |
Why?
|
| Rats, Inbred F344 | 2 | 2024 | 245 | 0.110 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 37 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2013 | 517 | 0.110 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2011 | 19 | 0.100 |
Why?
|
| Functional Laterality | 3 | 2018 | 80 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 893 | 0.100 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 385 | 0.100 |
Why?
|
| Ethanol | 1 | 2013 | 192 | 0.100 |
Why?
|
| Phenols | 1 | 2011 | 80 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2018 | 1908 | 0.090 |
Why?
|
| Emetine | 2 | 2005 | 13 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 3 | 2005 | 223 | 0.080 |
Why?
|
| N-Ethylmaleimide-Sensitive Proteins | 1 | 2008 | 1 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 1180 | 0.080 |
Why?
|
| Methadyl Acetate | 1 | 2008 | 1 | 0.080 |
Why?
|
| Receptor, trkB | 1 | 2008 | 14 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 1568 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 143 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2005 | 928 | 0.070 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 107 | 0.070 |
Why?
|
| Anxiety | 1 | 2013 | 754 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 435 | 0.070 |
Why?
|
| Anisomycin | 1 | 2005 | 8 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 136 | 0.060 |
Why?
|
| Dendrites | 1 | 2005 | 55 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 212 | 0.060 |
Why?
|
| Diazoxide | 1 | 2024 | 5 | 0.060 |
Why?
|
| Brain Mapping | 2 | 2014 | 112 | 0.060 |
Why?
|
| Pregnancy | 2 | 2008 | 1549 | 0.060 |
Why?
|
| Olfactory Bulb | 2 | 1995 | 48 | 0.060 |
Why?
|
| Humans | 8 | 2022 | 37093 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2002 | 137 | 0.050 |
Why?
|
| Receptors, Prostaglandin | 1 | 2022 | 10 | 0.050 |
Why?
|
| Presenilin-1 | 1 | 2022 | 27 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2005 | 308 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2005 | 305 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2022 | 27 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2022 | 63 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 61 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2022 | 95 | 0.050 |
Why?
|
| Canada | 1 | 2021 | 130 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2003 | 1207 | 0.050 |
Why?
|
| Time Factors | 4 | 2006 | 1742 | 0.050 |
Why?
|
| Anorexia | 1 | 2020 | 5 | 0.050 |
Why?
|
| GAP-43 Protein | 1 | 2000 | 9 | 0.050 |
Why?
|
| Social Behavior | 1 | 2021 | 131 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2000 | 48 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2000 | 87 | 0.040 |
Why?
|
| Alkaloids | 2 | 2002 | 39 | 0.040 |
Why?
|
| Electric Stimulation | 3 | 2006 | 184 | 0.040 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2019 | 12 | 0.040 |
Why?
|
| Ventral Tegmental Area | 1 | 2019 | 36 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 33 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2018 | 32 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 78 | 0.040 |
Why?
|
| Parkinsonian Disorders | 1 | 2018 | 37 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 75 | 0.040 |
Why?
|
| Calpain | 1 | 2018 | 35 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 43 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 130 | 0.040 |
Why?
|
| Chlordiazepoxide | 1 | 2017 | 1 | 0.040 |
Why?
|
| Taste Perception | 1 | 2017 | 3 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 689 | 0.040 |
Why?
|
| Ketamine | 1 | 2017 | 11 | 0.040 |
Why?
|
| Orchiectomy | 1 | 2017 | 35 | 0.040 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 17 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 121 | 0.040 |
Why?
|
| Psychological Tests | 1 | 2017 | 53 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 50 | 0.040 |
Why?
|
| Visual Perception | 1 | 2017 | 67 | 0.040 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2016 | 15 | 0.040 |
Why?
|
| Olfactory Perception | 1 | 2016 | 6 | 0.040 |
Why?
|
| Predatory Behavior | 1 | 2016 | 15 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2018 | 492 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 1039 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 2016 | 73 | 0.030 |
Why?
|
| Injections | 1 | 1995 | 35 | 0.030 |
Why?
|
| Neostriatum | 1 | 1995 | 26 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 434 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1994 | 2 | 0.030 |
Why?
|
| Angiomyolipoma | 1 | 1994 | 2 | 0.030 |
Why?
|
| Staurosporine | 2 | 2006 | 38 | 0.030 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1994 | 9 | 0.030 |
Why?
|
| Motor Activity | 1 | 2017 | 418 | 0.030 |
Why?
|
| Amnesia | 1 | 1994 | 8 | 0.030 |
Why?
|
| Bradykinin | 1 | 1994 | 22 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1993 | 14 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2014 | 47 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 1995 | 104 | 0.030 |
Why?
|
| Brain Stem | 1 | 1994 | 50 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2014 | 124 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1994 | 68 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1994 | 140 | 0.030 |
Why?
|
| Arteriosclerosis | 2 | 1971 | 36 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1993 | 100 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 173 | 0.030 |
Why?
|
| Receptors, GABA | 1 | 2013 | 25 | 0.030 |
Why?
|
| Ouabain | 1 | 1992 | 15 | 0.030 |
Why?
|
| Glutamates | 1 | 1992 | 22 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 1992 | 48 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 1971 | 36 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2011 | 43 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1971 | 64 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1992 | 128 | 0.020 |
Why?
|
| Calcium | 1 | 1994 | 480 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 481 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 803 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1971 | 90 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 859 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1971 | 124 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 233 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 302 | 0.020 |
Why?
|
| Perforant Pathway | 1 | 2006 | 15 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2006 | 39 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 55 | 0.020 |
Why?
|
| Depression | 1 | 2013 | 712 | 0.020 |
Why?
|
| Child | 1 | 2014 | 3131 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 5363 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 21 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 103 | 0.020 |
Why?
|
| Sirolimus | 1 | 2005 | 60 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 90 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2003 | 109 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 207 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 191 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 133 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2003 | 128 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 408 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 997 | 0.010 |
Why?
|
| Time | 1 | 2000 | 14 | 0.010 |
Why?
|
| Xenopus | 1 | 2000 | 48 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 111 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 129 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2000 | 99 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 433 | 0.010 |
Why?
|
| Oocytes | 1 | 2000 | 146 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 523 | 0.010 |
Why?
|
| Hypercholesterolemia | 2 | 1971 | 38 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 286 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1994 | 48 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1994 | 27 | 0.010 |
Why?
|
| Cytosol | 1 | 1994 | 93 | 0.010 |
Why?
|
| Biological Transport | 1 | 1994 | 185 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1994 | 128 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1971 | 21 | 0.010 |
Why?
|
| Triglycerides | 1 | 1971 | 138 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1971 | 119 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1994 | 1518 | 0.010 |
Why?
|
| Adult | 2 | 1994 | 11712 | 0.000 |
Why?
|
| Androstanols | 1 | 1964 | 1 | 0.000 |
Why?
|
| Xanthomatosis | 1 | 1964 | 5 | 0.000 |
Why?
|
| Pharmacology | 1 | 1964 | 5 | 0.000 |
Why?
|
| Anabolic Agents | 1 | 1964 | 18 | 0.000 |
Why?
|
| Steroids | 1 | 1964 | 43 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1964 | 117 | 0.000 |
Why?
|
| Aged | 1 | 1971 | 6741 | 0.000 |
Why?
|
| Middle Aged | 1 | 1971 | 10129 | 0.000 |
Why?
|